113 related articles for article (PubMed ID: 7536147)
1. [CD5+B cells and autoimmune diseases].
Yu JR; Qiu ZX; Yang H
Zhonghua Nei Ke Za Zhi; 1994 Sep; 33(9):590-2. PubMed ID: 7536147
[TBL] [Abstract][Full Text] [Related]
2. B cells expressing CD5 antigen are markedly increased in peripheral blood and spleen lymphocytes from patients with immune thrombocytopenic purpura.
Mizutani H; Furubayashi T; Kashiwagi H; Honda S; Take H; Kurata Y; Yonezawa T; Tarui S
Br J Haematol; 1991 Aug; 78(4):474-9. PubMed ID: 1716955
[TBL] [Abstract][Full Text] [Related]
3. Marked increase of CD5 + B cells in hyperthyroid Graves' disease.
Iwatani Y; Amino N; Kaneda T; Ichihara K; Tamaki H; Tachi J; Matsuzuka F; Fukata S; Kuma K; Miyai K
Clin Exp Immunol; 1989 Nov; 78(2):196-200. PubMed ID: 12412748
[TBL] [Abstract][Full Text] [Related]
4. Both splenic CD5(+) B and CD5(-) B cells produce platelet glycoprotein-specific autoantibodies in chronic ITP.
Hou M; Lv B; He Q; Lu L; Shi Y; Ji X; Ma D; Zhang M
Thromb Res; 2003 Apr; 110(1):1-5. PubMed ID: 12877901
[TBL] [Abstract][Full Text] [Related]
5. CD5+ B lymphocytes and other lymphocyte subsets in primary Sjögren's syndrome.
van de Merwe JP; van den Beemd MW; Hooijkaas H
Neth J Med; 1992 Apr; 40(3-4):158-64. PubMed ID: 1376444
[TBL] [Abstract][Full Text] [Related]
6. B-cell subsets and platelet counts in HIV-1 seropositive subjects.
Kouri YH; Basch RS; Karpatkin S
Lancet; 1992 Jun; 339(8807):1445-6. PubMed ID: 1376384
[TBL] [Abstract][Full Text] [Related]
7. CD5-positive B cells at the crossroads of B cell malignancy and nonorgan-specific autoimmunity.
Youinou P; Pers JO; Jamin C; Lydyard PM
Pathol Biol (Paris); 2000 Jul; 48(6):574-6. PubMed ID: 10965537
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice.
Morshed SR; Mannoor K; Halder RC; Kawamura H; Bannai M; Sekikawa H; Watanabe H; Abo T
Eur J Immunol; 2002 Sep; 32(9):2551-61. PubMed ID: 12207339
[TBL] [Abstract][Full Text] [Related]
9. CD5+ B lymphocytes and CD4+ CD45RA+ T cells in Graves' disease.
Afeltra A; Paggi A; Ferri GM; Amoroso A; Di Prima MA; Startari S; Faralli AR; Bonomo L
Endocr Res; 1993 Mar; 19(1):73-85. PubMed ID: 7681770
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseases.
Markeljević J; Batinić D; Uzarević B; Bozikov J; Cikes N; Babić-Naglić D; Horvat Z; Marusić M
J Rheumatol; 1994 Dec; 21(12):2225-30. PubMed ID: 7535356
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of IL-2 hyper-responsive NZB/WF1 CD5- B cells.
Hirose S; Nakanishi K; Yoshimoto T; Kashiwamura S; Hiroishi K; Matsumoto H; Hamaoka T; Shinka S; Higashino K
J Immunol; 1994 Aug; 153(4):1847-57. PubMed ID: 7519217
[TBL] [Abstract][Full Text] [Related]
12. Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies.
Kasaian MT; Ikematsu H; Casali P
J Immunol; 1992 May; 148(9):2690-702. PubMed ID: 1374094
[TBL] [Abstract][Full Text] [Related]
13. CD5+ B lymphocytes in HIV infection: relationship to immunological progression of disease.
Sampalo A; López-Gómez M; Jiménez-Alonso J; Ortiz F; Samaniego F; Garrido F
Clin Immunol Immunopathol; 1993 Mar; 66(3):260-8. PubMed ID: 7679344
[TBL] [Abstract][Full Text] [Related]
14. CD5+ B cells as precursors of CD5- IgG anti-DNA antibody-producing B cells in autoimmune-prone NZB/W F1 mice.
Kanno K; Okada T; Abe M; Hirose S; Shirai T
Ann N Y Acad Sci; 1992 May; 651():576-8. PubMed ID: 1376080
[No Abstract] [Full Text] [Related]
15. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry.
Chan JY; Walfish PG
J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483
[TBL] [Abstract][Full Text] [Related]
16. Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation.
Fischer M; Klein U; Küppers R
J Clin Invest; 1997 Oct; 100(7):1667-76. PubMed ID: 9312164
[TBL] [Abstract][Full Text] [Related]
17. [Participation of bonth splenic CD(5)(+) and CD(5)(-) B lymphocytes in production of platelet glycoprotein-specific autoantibodies in chronic ITP].
Lu B; Hou M; Lu L; Shi Y; He Q; Ma D; Zhang M
Zhonghua Xue Ye Xue Za Zhi; 2002 Sep; 23(9):460-2. PubMed ID: 12482355
[TBL] [Abstract][Full Text] [Related]
18. Expression of activated molecules on CD5(+)B lymphocytes in autoimmune hemolytic anemia.
Zhu H; Xu W; Liu H; Wang H; Fu R; Wu Y; Qu W; Wang G; Guan J; Song J; Xing L; Shao Z
Int J Hematol; 2016 May; 103(5):545-53. PubMed ID: 26968550
[TBL] [Abstract][Full Text] [Related]
19. Analysis of RAG expression by peripheral blood CD5+ and CD5- B cells of patients with childhood systemic lupus erythematosus.
Morbach H; Singh SK; Faber C; Lipsky PE; Girschick HJ
Ann Rheum Dis; 2006 Apr; 65(4):482-7. PubMed ID: 16126793
[TBL] [Abstract][Full Text] [Related]
20. [The clinical significance of immune-related marker detection in idiopathic thrombocytopenic purpura].
Chen JF; Yang LH; Feng JJ; Chang LX; Liu XE; Lu YJ
Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):765-8. PubMed ID: 21092448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]